| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 151,463 | 202,913 | 216,416 | 272,427 | | Cost of Revenue | 112,870 | 162,527 | 176,692 | 224,458 | | | Gross Profit | 38,593 | 40,386 | 39,724 | 47,969 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,036 | 10,048 | 11,511 | 12,569 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 14,071 | 13,835 | 13,165 | 16,062 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,598 | 16,503 | 15,048 | 19,338 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,065 | 8 | 3,985 | 15,355 | | Earnings Before Interest And Taxes | 18,080 | 18,610 | 20,517 | 34,228 | | Interest Expense | 15,440 | 12,001 | 14,448 | 22,039 | | Income Before Tax | 2,640 | 6,609 | 6,069 | 12,189 | | Income Tax Expense | 304 | 571 | 164 | 403 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,336 | 6,038 | 5,905 | 11,786 | | | Non-recurring Events | | Discontinued Operations | 1,393 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,729 | 6,038 | 5,905 | 11,786 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,729 | $6,038 | $5,905 | $11,786 |
|
0.51% Nasdaq 
Income Statement
